Bone morphogenetic protein 2 signals via BMPR1A to regulate murine follicle-stimulating hormone beta subunit transcription

Biology of Reproduction

Volumn 81, Issue 1, 2009, Pages 133-141

  Ho, Catherine C ^a   Bernard, Daniel J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

ALK3; ALK6; Anterior pituitary; BMP; BMPR2; Booroola; FecB; Follicle stimulating hormone; FSH; Gonadotroph; Pituitary; Signal transduction; SMAD; TGFB

Indexed keywords

ACTIVIN A; ACTIVIN A RECEPTOR TYPE I; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; FOLLITROPIN BETA SUBUNIT; MUTANT PROTEIN; RECEPTOR PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE ACTIVITY; GENE MUTATION; GENETIC TRANSCRIPTION; GONADOTROPIN SECRETING CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GENE EXPRESSION REGULATION; GONADOTROPHS; HUMANS; MICE; MUTATION, MISSENSE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

MURINAE; OVIS ARIES;

EID: 67649650258     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.108.074211     Document Type: Article

References (46)

1. Dupont J, McNeilly J, Vaiman A, Canepa S, Combarnous Y, Taragnat C. Activin signaling pathways in ovine pituitary and LbetaT2 gonadotrope cells. Biol Reprod 2003; 68:1877-1887. (Pubitemid 36519798)
2. Bernard DJ. Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells. Mol Endocrinol 2004; 18:606-623. (Pubitemid 38328206)
3. Suszko MI, Balkin DM, Chen Y, Woodruff TK. Smad3 mediates activin-induced transcription of follicle-stimulating hormone beta-subunit gene. Mol Endocrinol 2005; 19:1849-1858. (Pubitemid 41007896)
4. Lamba P, Santos MM, Philips DP, Bernard DJ. Acute regulation of murine follicle-stimulating hormone beta subunit transcription by activin A. J Mol Endocrinol 2006; 36:201-220. (Pubitemid 43273676)
5. Bernard DJ, Lee KB, Santos MM. Activin B can signal through both ALK4 and ALK7 in gonadotrope cells. Reprod Biol Endocrinol 2006; 4:e52. (Pubitemid 44642560)
6. Harrison CA, Gray PC, Vale WW, Robertson DM. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005; 16:73-78. (Pubitemid 40270853)
7. Lee KB, Khivansara V, Santos MM, Lamba P, Yuen T, Sealfon SC, Bernard DJ. Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription. J Mol Endocrinol 2007; 38:315-330. (Pubitemid 46351612)
8. Huang HJ, Wu JC, Su P, Zhirnov O, Miller WL. A novel role for bone morphogenetic proteins in the synthesis of follicle-stimulating hormone. Endocrinology 2001; 142:2275-2283. (Pubitemid 32473081)
9. Otsuka F, Shimasaki S. A novel function of bone morphogenetic protein-15 in the pituitary: selective synthesis and secretion of FSH by gonadotropes. Endocrinology 2002; 143:4938-4941. (Pubitemid 35397634)
10. Nicol L, Faure MO, McNeilly JR, Fontaine J, Taragnat C, McNeilly AS. Bone morphogenetic protein-4 interacts with activin and GnRH to modulate gonadotrophin secretion in LbetaT2 gonadotrophs. J Endocrinol 2008; 196:497-507.
11. Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 1999; 25:91-93. (Pubitemid 29322068)
12. Allendorph GP, Vale WW, Choe S. Structure of the ternary signaling complex of a TGF-beta superfamily member. Proc Natl Acad Sci U S A 2006; 103:7643-7648. (Pubitemid 43752834)
13. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 2002; 7:1191-1204. (Pubitemid 36024597)
14. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005; 19:2783-2810. (Pubitemid 41739965)
15. Suszko MI, Lo DJ, Suh H, Camper SA, Woodruff TK. Regulation of the rat follicle-stimulating hormone beta-subunit promoter by activin. Mol Endocrinol 2003; 17:318-332. (Pubitemid 36315627)
16. Yu PB, Beppu H, Kawai N, Li E, Bloch KD. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J Biol Chem 2005; 280:24443-24450. (Pubitemid 40934529)
17. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 2004; 25:72-101. (Pubitemid 38292039)
18. Suszko MI, Woodruff TK. Cell-specificity of transforming growth factor-beta response is dictated by receptor bioavailability. J Mol Endocrinol 2006; 36:591-600. (Pubitemid 43904949)
19. Davis GH, Montgomery GW, Allison AJ, Kelly RW, Bray AR. Segregation of a major gene influencing fecundity in progeny of Booroola sheep. N Z J Agric Res 1982; 25:525-529.
20. Piper LR. The single gene inheritance of the high litter size of the Booroola Merino. In: Land RB, Robinson DW (eds.), Genetics of Reproduction in Sheep. London: Butterworths; 1985:115-125.
21. Monget P, Fabre S, Mulsant P, Lecerf F, Elsen JM, Mazerbourg S, Pisselet C, Monniaux D. Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals. Domest Anim Endocrinol 2002; 23:139-154. (Pubitemid 34894582)
22. McNatty KP, Hudson N, Henderson KM, Gibb M, Morrison L, Ball K, Smith P. Differences in gonadotrophin concentrations and pituitary responsiveness to GnRH between Booroola ewes which were homozygous (FF), heterozygous (F+) and non-carriers (++) of a major gene influencing their ovulation rate. J Reprod Fertil 1987; 80:577-588. (Pubitemid 17097798)
23. Mulsant P, Lecerf F, Fabre S, Schibler L, Monget P, Lanneluc I, Pisselet C, Riquet J, Monniaux D, Callebaut I, Cribiu E, Thimonier J, et al. Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Merino ewes. Proc Natl Acad Sci U S A 2001; 98:5104-5109. (Pubitemid 32397090)
24. Souza CJ, MacDougall C, Campbell BK, McNeilly AS, Baird DT. The Booroola (FecB) phenotype is associated with a mutation in the bone morphogenetic receptor type 1 B (BMPR1B) gene. J Endocrinol 2001; 169:R1-R6. (Pubitemid 32447622)
25. Wilson T, Wu XY, Juengel JL, Ross IK, Lumsden JM, Lord EA, Dodds KG, Walling GA, McEwan JC, O'Connell AR, McNatty KP, Montgomery GW. Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biol Reprod 2001; 64:1225-1235. (Pubitemid 32239195)
26. Campbell BK, Baird DT, Souza CJ, Webb R. The FecB (Booroola) gene acts at the ovary: in vivo evidence. Reproduction 2003; 126:101-111. (Pubitemid 36850185)
27. Fabre S, Pierre A, Pisselet C, Mulsant P, Lecerf F, Pohl J, Monget P, Monniaux D. The Booroola mutation in sheep is associated with an alteration of the bone morphogenetic protein receptor-IB functionality. J Endocrinol 2003; 177:435-444. (Pubitemid 36722299)
28. Young JM, Juengel JL, Dodds KG, Laird M, Dearden PK, McNeilly AS, McNatty KP, Wilson T. The activin receptor-like kinase 6 Booroola mutation enhances suppressive effects of bone morphogenetic protein 2 (BMP2), BMP4, BMP6 and growth and differentiation factor-9 on FSH release from ovine primary pituitary cell cultures. J Endocrinol 2008; 196:251-261. (Pubitemid 351298510)
29. Faure MO, Nicol L, Fabre S, Fontaine J, Mohoric N, McNeilly A, Taragnat C. BMP-4 inhibits follicle-stimulating hormone secretion in ewe pituitary. J Endocrinol 2005; 186:109-121. (Pubitemid 41015669)
30. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22:2990-2997. (Pubitemid 24260626)
31. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992; 89:1827-1831.
32. Liu F, Ventura F, Doody J, Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 1995; 15:3479-3486.
33. Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massague J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 2000; 100:229-240. (Pubitemid 30064911)
34. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62:65-74. (Pubitemid 34680517)
35. Persson U, Izumi H, Souchelnytskyi S, Itoh S, Grimsby S, Engstrom U, Heldin CH, Funa K, ten Dijke P. The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation. FEBS Lett 1998; 434:83-87.
36. Chen YG, Hata A, Lo RS, Wotton D, Shi Y, Pavletich N, Massague J. Determinants of specificity in TGF-beta signal transduction. Genes Dev 1998; 12:2144-2152. (Pubitemid 28348038)
37. Feng XH, Derynck R. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. EMBO J 1997; 16:3912-3923. (Pubitemid 27281007)
38. Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH, ten Dijke P. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J Biol Chem 2003; 278:3751-3761. (Pubitemid 36801101)
39. Clouaire T, Stancheva I. Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin? Cell Mol Life Sci 2008; 65:1509-1522.
40. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 2008; 4:33-41. (Pubitemid 350273653)
41. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH, Miyazono K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 1995; 130:217-226.
42. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A 1995; 92:7632-7636.
43. Kawabata M, Chytil A, Moses HL. Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor. J Biol Chem 1995; 270:5625-5630.
44. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 1994; 269:16985-16988.
45. Bindon BM. Reproductive biology of the Booroola Merino sheep. Aust J Biol Sci 1984; 37:163-189.
46. Robertson DM, Ellis S, Foulds LM, Findlay JK, Bindon BM. Pituitary gonadotrophins in Booroola and control Merino sheep. J Reprod Fertil 1984; 71:189-197. (Pubitemid 14104451)